Curtis T. Keith

Director/Board Member at Translational Development Acquisition Corp.

53 year

Consumer Services

Health Technology

Finance

Profile

Curtis T.
Keith was the founder of CombinatoRx, Inc. which was founded in 2000, where he held the title of Senior Vice President-Research from 2000 to 2008.
Currently, he is a Director at Translational Development Acquisition Corp.
Dr. Keith's education history includes a graduate and doctorate degree from Harvard University and an undergraduate degree from McGill University.

Curtis T. Keith active positions

Companies	Position	Start
Translational Development Acquisition Corp. Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.	Director/Board Member	-

All active positions of Curtis T. Keith

Former positions of Curtis T. Keith

Companies	Position	End
CombinatoRx, Inc. CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA	Founder	06/02/2008

See the detail of Curtis T. Keith's experience

Training of Curtis T. Keith

Harvard University	Doctorate Degree
McGill University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Curtis T. Keith's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
CombinatoRx, Inc. CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA	Health Technology
Translational Development Acquisition Corp. Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.	Finance